Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk.

Abstract excerpt

AIMS/HYPOTHESIS: To examine the role of additional immune, genetic and metabolic risk markers in determining risk of diabetes in islet cell antibody (ICA)-positive individuals with a family history of type 1 diabetes recruited into the European Nicotinamide Diabetes Intervention Trial. METHODS: F...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Age of Onset
• Share to Autoantibodies
• Share to Diabetes Mellitus, Type 1